Data / Form D filings / GlycosBio Inc.
GlycosBio Inc.: Form D filings
GlycosBio Inc., a biotechnology company in Houston, TX, filed 8 Form D notices with the SEC between 2009 and 2024. The latest, on March 21, 2024, reports $1.1 million sold of a $5 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 Holcombe, Suite J, Houston, TX, 77021
- Phone
- (281) 643-7234
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1427515
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 21, 2024 | New notice | $5,000,000 | $1,125,000 | $3,875,000 | 5 | Mar 6, 2024 | sec.gov |
| Apr 7, 2023 | New notice | $1,000,000 | $425,000 | $575,000 | 3 | Mar 30, 2023 | sec.gov |
| Jan 4, 2017 | New notice | $930,000 | $829,846 | $100,154 | 15 | Dec 14, 2016 | sec.gov |
| Oct 11, 2013 | New notice | $1,500,000 | $375,250 | $1,124,750 | 3 | Sep 25, 2013 | sec.gov |
| Feb 28, 2013 | New notice | $5,000,000 | $3,000,000 | $2,000,000 | 1 | Feb 15, 2013 | sec.gov |
| Oct 20, 2010 | New notice | $12,000,000 | $4,220,385 | $7,779,615 | 15 | Oct 8, 2010 | sec.gov |
| Oct 20, 2010 | New notice | $12,000,000 | $4,220,385 | $7,779,615 | 15 | Oct 8, 2010 | sec.gov |
| Apr 7, 2009 | New notice | $3,250,000 | $2,350,000 | $900,000 | 4 | Mar 24, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Victoria C. Jr. Niklas | Director | |
| John C. Jr. Replogle | Director | |
| Richard C. Jr. Cilento | Executive Officer, Director | |
| Frank C. Jr. Foster | Director | |
| Joseph C. Jr. Walowski | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Mar 18, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GlycosBio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.